Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody.

Zhang J, Lou J

Open source

DOI
10.1155/2022/9086962
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/9086962,
  title = {Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody.},
  author = {Zhang J and Lou J},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/9086962},
  url = {https://doi.org/10.1155/2022/9086962}
}

RIS

TY  - JOUR
TI  - Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody.
AU  - Zhang J
AU  - Lou J
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/9086962
UR  - https://doi.org/10.1155/2022/9086962
ER  - 

APA

J, Z., & J, L. (2022). Risk Factors for Thyroid Dysfunction in Patients with Advanced Non-Small-Cell Lung Cancer Treated with PD-1 Antibody.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/9086962

Source records